ECM
DARE icon

ETrade Capital Management’s Dare Bioscience DARE Stock Holding History

ETrade Capital Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,271
Closed -$15K – 900
2020
Q2 		$15K Hold
1,271
– – ﹤0.01% 838
2020
Q1 		$13K Buy
+1,271
New +$17.1K ﹤0.01% 749

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.95B AUM 22.17% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

ETrade Capital Management's DARE Position: Q3 2020 in Review

ETrade Capital Management sold out of Dare Bioscience (DARE) in Q3 2020, closing a stake of 1,271 shares — an estimated $15K sold.

ETrade Capital Management first reported a position in DARE in Q1 2020 and held it in 2 quarters. The position peaked at $15K in Q2 2020. 21 funds tracked by Wall St. Rank hold DARE as of Q3 2020.

  • ETrade Capital Management reported no remaining Dare Bioscience position as of Q3 2020 after selling out during the quarter.
  • ETrade Capital Management sold 1,271 Dare Bioscience shares in Q3 2020, an estimated $15K.
  • ETrade Capital Management first reported a position in Dare Bioscience in Q1 2020 and held it in 2 quarters.
  • ETrade Capital Management's Dare Bioscience position peaked at $15K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.